KUALA LUMPUR, Jan 14 (NNN-Bernama) – Malaysia was featured as the Hepatitis C Treatment Hub of Asia at Expo 2020 Dubai during the opening ceremony of Malaysia Healthcare Excellence week at the Malaysia Pavilion, according to the Malaysia Healthcare Travel Council (MHTC).
MHTC, in a statement Friday, said being the first country in the world to be given conditional approval for Ravidasvir in combination with Sofosbuvir to treat Hepatitis C, Malaysia is ready to offer access to an affordable and efficacious treatment solution.
“In response to the World Hepatitis Day 2021 theme, “Hepatitis Can’t Wait”, Malaysia is ready and raring to move forward with a treatment solution for those infected with the disease.
“Malaysia is offering Hepatitis C patients a treatment with a cure rate of 97 per cent and cost reduction of 95 per cent,” said MHTC chief executive officer Mohd Daud Mohd Arif at the opening ceremony of Malaysia Healthcare Excellence week.
Mohd Daud said as Malaysia’s healthcare moves towards industry recovery, it is even more important for them to showcase the strength of their healthcare offerings and remain top of mind as a leading global healthcare destination.